Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Massive rollback coming
View:
Post by goldtech on Aug 18, 2021 10:02am

Massive rollback coming

Elliott and Gene orchestrated the worst deal in the companies history and will now initiate a massive 10 to 1 rollback. This does not effect them as their options are huge and their free shares and cash are more then they could have dreamed to screw you all.
Comment by M101 on Aug 18, 2021 11:05am
The market will take notice of how this 100 million shares is digested, be it quickly, painfully or not completely. It will be 1/4 of outstanding when done so maybe a new or significant voting block will be created, beyond what the consultants were willng to accept a year ago.  How this goes down right now will determine the risk in any potential roll back before clinicals results begin.
Comment by M101 on Aug 18, 2021 11:15am
Oops, the offering just increased so that answers my question.  So now I want to know at what price pp holders are still willing to churn to get that 1/4 warrant? .18? bit of a risk with strong buying interest so maybe .20 holds?  
Comment by Thenorth1990 on Aug 18, 2021 11:53am
Only serology news can save us pr what until ph1 I guess
Comment by Mole101 on Aug 18, 2021 1:26pm
Great time to buy again, I increased my position to over 1.2 million,There are lots of things happening and positive NRs coming our way ,We should see them lining up very soon ..with the Boston group on board, Rudi Tanzi heading the advisory board and a new CEO coming up in the nest few months and results from the cell line development for PMN310...Not happy to see such a share dilution but ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities